Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (631-640 of 715) with videos related to

Pageof 72
Sort By:
The American Journal of Pathology|February 1, 1997
Vascular wound healing and neointima formation induced by perivascular electric injury in miceP Carmeliet, L Moons, J M Stassen, et al.
European Journal of Biochemistry|December 15, 1992
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
Journal of Medical Genetics|May 3, 2005
Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathyT Rossenbacker, E Schollen, C Kuipéri, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Thrombosis and Haemostasis|June 1, 1992
G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogsH R Lu, H K Gold, Z Wu, et al.
Radiology|April 1, 1989
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit modelY Hashimoto, J M Stassen, B Leclef, et al.
Blood|August 15, 1991
Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivoM Dewerchin, H R Lijnen, J M Stassen, et al.
The Journal of Biological Chemistry|August 25, 1987
Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activatorD Gheysen, H R Lijnen, L Piérard, et al.
Klinische Wochenschrift|January 1, 1988
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]M Verstraete, M Bory, D Collen, et al.
Blood|May 11, 1999
Structure-function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal developmentE M Conway, S Pollefeyt, J Cornelissen, et al.
Pageof 72

Showing results (631-640 of 715) with videos related to

Sort By:
Pageof 72
The American Journal of Pathology|February 1, 1997
Vascular wound healing and neointima formation induced by perivascular electric injury in miceP Carmeliet, L Moons, J M Stassen, et al.
European Journal of Biochemistry|December 15, 1992
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
Journal of Medical Genetics|May 3, 2005
Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathyT Rossenbacker, E Schollen, C Kuipéri, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Thrombosis and Haemostasis|June 1, 1992
G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogsH R Lu, H K Gold, Z Wu, et al.
Radiology|April 1, 1989
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit modelY Hashimoto, J M Stassen, B Leclef, et al.
Blood|August 15, 1991
Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivoM Dewerchin, H R Lijnen, J M Stassen, et al.
The Journal of Biological Chemistry|August 25, 1987
Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activatorD Gheysen, H R Lijnen, L Piérard, et al.
Klinische Wochenschrift|January 1, 1988
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]M Verstraete, M Bory, D Collen, et al.
Blood|May 11, 1999
Structure-function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal developmentE M Conway, S Pollefeyt, J Cornelissen, et al.
Pageof 72